⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 2, 2024

Supplementary Figure 11 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling

Ruyi Zhang Shanshan Li Kelly Schippers Yunlong Li Boaz Eimers Marla Lavrijsen Ling Wang Guofei Cui Xin Chen Maikel P. Peppelenbosch Joyce H.G. Lebbink Ron Smits

View Full Paper

Ask AI

Bookmark

Share

Abstract

Deleting part of the RGS/APC domain at endogenous levels results in increased β-catenin signaling

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhang et al. (2024) studied this question.

synapsesocial.com/papers/68e6bea1b6db64358763ea0f https://doi.org/10.1158/0008-5472.25736006

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 11 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling2024
2Supplementary Figure 13 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling2024
3Supplementary Figure 13 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling2024
4Supplementary Figure 10 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling2024
5Supplementary Figure 10 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling2024